When was aphranel founded?

aphranel was founded in 2020 and raised its 1st funding round 6 years after it was founded.

Where is aphranel located?

aphranel is headquartered in Shanghai, China.

Is aphranel a funded company?

aphranel is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Sep 28, 2026.

When was the latest funding round of aphranel?

aphranel's latest funding was a $***** Seed round on Sep 28, 2026, with participation from 1 investor.

Where does aphranel rank among its competitors?

aphranel ranks 16th amongst 46 active competitors, of which 3 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was aphranel, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of aphranel?

aphranel's top competitors include Biotech Healthcare, Biotech Vision Care and Skin Tech Pharma Group. Among them, aphranel secured the most recent funding round in September, 2026.

aphranel - 2026 Company Profile, Funding & Competitors

Company Details

Manufacturer of calcium hydroxylapatite dermal fillers for aesthetic medical applications. These injectable products provide structural support to facial tissues and stimulate collagen production. The materials are designed to be fully degradable within the body over time. These medical devices are intended for use by qualified practitioners to address facial volume loss and support tissue regeneration.

Website: www.aphranel.com/
Email ID: *****@mybiotec.com
Phone Number: +86 **********

Key Metrics

Founded Year

2020

Location

Shanghai, China

Stage

Seed

Latest Funding Round

Seed, Sep 28, 2026, $*****

Investors

Cathay Capital

Ranked

16^th among 46 active competitors

Similar Companies

Biotech Healthcare & 45 more

View aphranel's full profile

aphranel has raised funding over 1 round. Its latest funding round was a Seed round on Sep 28, 2026 for $*****. 1 investor participated in its latest round. aphranel has 1 institutional investor.

Here is the list of recent funding rounds of aphranel:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 28, 2026	4751821	Seed	6917490	2562630	6381834	6693230

Access funding benchmarks and valuations. Sign up today!

View details of aphranel's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of aphranel include Biotech Healthcare, Biotech Vision Care and Skin Tech Pharma Group. Here is the list of Top 10 competitors of aphranel, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biotech Healthcare 1999, Lucerne (Switzerland), Unfunded	Manufacturer of ophthalmic, orthopedic, and aesthetic medical products. The company develops and produces intraocular lenses, viscosupplements, and dermal fillers. Its ophthalmology products support cataract and refractive surgery, while its orthopedics offerings address joint pain and mobility. The aesthetics product line focuses on skin rejuvenation. The company's manufacturing facilities utilize advanced technologies to ensure product quality and efficacy.	-	-	42/100
2nd	Biotech Vision Care 1998, Ahmedabad (India), Unfunded	Developer of ophthalmic surgical and eye care products	-	-	40/100
3rd	Skin Tech Pharma Group 1996, Castello d'Empuries (Spain), Funding Raised	Developer of technologies and products in the aesthetic medicine field	-	Charterhouse Capital Partners	36/100
4th	Vaim South Korea, Unfunded	Manufacturer of tissue regenerative medical products and improved pharmaceutical items	-	-	32/100
5th	Aesthetics Zone 2018, Delhi (India), Unfunded	Developer of skin care and aesthetic treatments for facial rejuvenation and restoration	-	-	30/100
6th	VIVACY 2007, Paris (France), Funding Raised	Manufacturer of dermo cosmetic products	-	TA Associates, Bridgepoint Capital & 3 others	29/100
7th	TruElastin 2010, Irvine (United States), Seed	Developer of a medical device that offers a technique for crosslinking and stabilizing natural elastin	$1.28M	-	29/100
8th	CellacBio 2024, Seoul (South Korea), Funding Raised	Manufacturer of medical devices pharmaceuticals cosmetics and biological tissue products	-	Korea Omega Investment Corp, V Platform Investment	27/100
9th	Neauvia 2012, Germany, Public	Developer of aesthetic medical devices and bio-regenerative and dermal filler products	-	-	26/100
10th	HALLURA 2017, Yokneam Illit (Israel), Series A	Developer of hyaluronic acid dermal fillers for aesthetic applications	$7M	Alon MedTech Ventures	26/100
16th	aphranel 2020, Shanghai (China), Seed	Manufacturer of calcium hydroxylapatite dermal fillers for aesthetic medical applications	-	Cathay Capital	22/100